Celebrities and influencers such as Oprah Winfrey, Elon Musk and Rachael Knight Guellete are confirmed to be using GLP-1s and will often be seen promoting these products
TRIUMPH-3 examines cardiovascular outcomes, enrolling adults with established cardiovascular disease and either obesity or type 2 diabetes
SGLT-2 inhibitors: a new mechanism for glycemic control
Not only does it have a tongue-twisting name, orforglipron has a complex molecular structure that made its synthesis very challenging
As obesity is a key risk factor for type 2 diabetes, cardiovascular disease, and other metabolic disorders, effective pharmacological interventions are increasingly sought after
If considering the Compounded Tablets tier: ask your assigned provider directly about the bioavailability and absorption pathway for compounded oral GLP-1 peptide medications, and what clinical evidence supports the specific oral formulation being prescribed